Granules India’s Paracetamol facility has successfully passed a USFDA inspection without any 483 observations. This facility has the world’s largest single API production line by volume.
Granules’ four API facilities have successfully passed USFDA inspections in the past 12 months. All of the company’s facilities including its finished dosage and PFI facility are approved by leading regulatory agencies including the USFDA, EDQM, Health Canada and Korean FDA.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
